Chief executive
Robert Ford
CHAIRMAN AND CEO · Abbott Laboratories
3 disclosed trades · 5 Feb 2025 to 25 Aug 2026 · latest filed 27 Aug 2026
Chief executive of Abbott Laboratories (ABT), tracked from the executive's own SEC Form 4 disclosures.
Recent disclosed trades
| Company | Trade date | Action | Amount |
|---|---|---|---|
| Common shares without par value (ABT) | 2026-08-25 | Sell | $46,204,798 |
| Common shares without par value (ABT) | 2026-01-23 | Buy | $2,013,967 |
| Common shares without par value (ABT) | 2025-02-05 | Sell | $37,435,200 |
Source: SEC Form 4 filings, trades from 5 Feb 2025 to 25 Aug 2026, latest filed 27 Aug 2026. Executives report their own trades on Form 4 within two business days.
Open the interactive profile: all trades, compare with others